Immediate Impact

37 standout
Sub-graph 1 of 15

Citing Papers

Role of SLC7A11/xCT in Ovarian Cancer
2024 Standout
Senolytics: from pharmacological inhibitors to immunotherapies, a promising future for patients’ treatment
2024 Standout
2 intermediate papers

Works of Haijun Li being referenced

Tyloxapol inhibits RANKL-stimulated osteoclastogenesis and ovariectomized-induced bone loss by restraining NF-κB and MAPK activation
2021
CircRNA LRP6 promotes the development of osteosarcoma via negatively regulating KLF2 and APC levels.
2019

Author Peers

Author Last Decade Papers Cites
Haijun Li 70 168 28 114 20 274
Xiaoxiao Han 52 117 20 56 16 238
Elham Kalantari 52 127 43 73 23 306
Zhongkai Zhang 30 190 16 81 14 332
Dominic Maggio 50 117 44 63 21 263
Weilai Tong 50 106 50 54 20 262
Bingjie Zheng 21 193 23 83 19 306
Jianming Yang 31 124 28 55 22 298
Xingyu Chang 33 143 16 91 15 226
Yongjin Li 82 128 18 33 14 243
Jiangbo Nie 29 126 39 56 17 266

All Works

Loading papers...

Rankless by CCL
2026